Heart test may end guesswork in AFib drug choice
NCT ID NCT05084495
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 22 times
Summary
This study looked at 50 people with atrial fibrillation who were starting a drug called flecainide. Researchers used advanced heart ultrasound and ECG tests to see if they could predict who would stay in normal rhythm and who would have side effects. The goal is to move away from trial-and-error prescribing and give the right drug to the right person from the start.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Sciences, Helsingborg Medical Faculty Lund University
Helsingborg, Skåne County, 25187, Sweden
Conditions
Explore the condition pages connected to this study.